University of California San Francisco
About UCSFQBI Highlights
Sep 24, 2026
A New Approach to Designing Bitopic Kinase Inhibitors
A new study introduces a framework for designing small molecules that engage two binding sites on the same protein, with potential applications in developing more precise drugs.
Aug 28, 2026
QBI Awarded $46 Million to Advance Autism Research
ARIA investment advances QBI's landmark Science study, accelerating the path from molecular discovery to new precision medicines for autism
Aug 28, 2026
The Molecular Map of Autism: A Road to Potential Drug Targets
Scientists studied 100 autism risk genes and found that many patient-derived mutations disrupt core biological processes; a discovery that opens new avenues for future interventions.
Aug 12, 2026
QBI Welcomes Brad Schneider as Chief Operating Officer
A global health and infectious disease leader with expertise in biotechnology and AI biosecurity brings scientific and operational experience to help strengthen QBI’s infrastructure and advance its translational impact.
Jul 25, 2026
Developers, Scientists, and Big Ideas: Inside the QBI Hackathon
The 2026 QBI Hackathon marked the largest edition of the event to date, bringing together 19 teams for 48 hours of collaboration at the intersection of biology, computation, and medicine.
Jun 27, 2026
A Study Maps How a Major Cancer Signaling Pathway Is Activated
A series of high-resolution molecular structures reveals how PI3Kα, a key regulator of cell growth and survival that is often altered in cancer, becomes activated at the cell membrane.
Jun 12, 2026
Researchers Uncover How HIV May Accelerate Cervical Cancer Development
A new study reveals how HIV-infected immune cells can reprogram cervical tissue and activate pathways linked to cancer progression
Jun 05, 2026
QBI Welcomes Andy Kilianksi as Chief Science and Technology Officer
A former ARPA-H leader and global health expert brings experience in translational science, technology innovation, and pandemic preparedness to help advance QBI’s mission and technology strategy.
May 14, 2026
From Bat to Bench
A New Study Reveals How Protein-to-Protein Interaction Mapping Decodes the Molecular Origins of Pandemic Viruses
May 13, 2026
QBI Welcomes John Young as Chief Strategy Officer
A veteran leader in pharma, infectious disease, and global health joins QBI to help accelerate the translation of PPI science into therapeutic impact and industry partnerships.
Apr 21, 2026
New CRISPR Study Uncovers Hidden Drivers and Blockers of HIV Infection
Researchers at QBI, UCSF, and Gladstone Institutes published a new Cell study delivering a comprehensive map of how HIV interacts with human proteins in primary immune cells.
Mar 17, 2026
QBI Turns 10!
On March 16, 2016, UCSF announced the establishment of the Quantitative Biosciences Institute, with a mission to connect researchers across disciplines and advance understanding of disease biology.
QBI incorporates the UCSF division of QB3, a multicampus UC institute that supports bioscience research and innovation in California
About QB3